K. Lance Anderson Quoted in Wall Street Journal on Innovation Spurred by Venture Investment in Crispr Gene Editing
K. Lance Anderson was quoted by The Wall Street Journal article, "Venture Investment in Crispr Gene Editing Spurs Innovation, Hunt for IP." Lance acknowledges the swift advances in gene-editing technology and postulates that companies will begin taking a focused approach when seeking patents on core aspects of their technology. To read the article, click here.
